全文获取类型
收费全文 | 588篇 |
免费 | 16篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 11篇 |
妇产科学 | 17篇 |
基础医学 | 42篇 |
口腔科学 | 7篇 |
临床医学 | 34篇 |
内科学 | 127篇 |
皮肤病学 | 6篇 |
神经病学 | 17篇 |
特种医学 | 79篇 |
外科学 | 110篇 |
综合类 | 5篇 |
预防医学 | 19篇 |
眼科学 | 2篇 |
药学 | 44篇 |
2篇 | |
中国医学 | 2篇 |
肿瘤学 | 93篇 |
出版年
2022年 | 4篇 |
2021年 | 10篇 |
2020年 | 5篇 |
2019年 | 11篇 |
2018年 | 9篇 |
2017年 | 5篇 |
2016年 | 7篇 |
2015年 | 10篇 |
2014年 | 13篇 |
2013年 | 15篇 |
2012年 | 16篇 |
2011年 | 15篇 |
2010年 | 12篇 |
2009年 | 15篇 |
2008年 | 13篇 |
2007年 | 26篇 |
2006年 | 23篇 |
2005年 | 17篇 |
2004年 | 19篇 |
2003年 | 17篇 |
2002年 | 16篇 |
2001年 | 18篇 |
2000年 | 24篇 |
1999年 | 13篇 |
1998年 | 22篇 |
1997年 | 21篇 |
1996年 | 17篇 |
1995年 | 13篇 |
1994年 | 17篇 |
1993年 | 12篇 |
1992年 | 10篇 |
1991年 | 4篇 |
1990年 | 9篇 |
1989年 | 21篇 |
1988年 | 20篇 |
1987年 | 22篇 |
1986年 | 14篇 |
1985年 | 12篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1982年 | 10篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1968年 | 2篇 |
1967年 | 3篇 |
排序方式: 共有618条查询结果,搜索用时 0 毫秒
101.
102.
103.
104.
105.
Yanamandra N Kondraganti S Gondi CS Gujrati M Olivero WC Dinh DH Rao JS 《International journal of cancer. Journal international du cancer》2005,115(6):998-1005
Recombinant adeno-associated viruses (rAAV) have become the vector of choice for many gene therapy protocols. rAAVs have a number of attractive features including long-term transgene expression and the ability to transduce both dividing and non-dividing cells. We have shown previously the anti-cancer role of tissue factor pathway inhibitor-2 (TFPI-2), a matrix-associated serine protease inhibitor, in human glioblastomas. As a result of our present study, in which 0.8-kb fragment of human TFPI-2 was cloned into the adeno-associated viral vectors (rAAA-TFPI-2), rAAV-TFPI-2 infection of SNB19 cells significantly increased TFPI-2 as determined by Western blotting. As assessed by spheroid and Matrigel assays, infection of SNB19 cells with rAAV-TFPI-2 significantly reduced migration and invasion in a dose-dependent manner. Tumor spheroids infected with rAAV-TFPI-2 and co-cultured with fetal rat brain aggregates did not invade rat brain aggregates, whereas 90-95% of the mock and AAV-CMV infected cells invaded rat brain aggregates. In vitro angiogenesis studies (tumor cells co-cultured with endothelial cells or endothelial cells seeded on matrigel) showed reduction of capillary-like structure formation in rAAV-TFPI-2-treated cells as compared to parental and mock-transfected cells. In in vivo angiogenesis results demonstrated the formation of microvessels in SNB19 parental cells and this formation was inhibited when the SNB19 cells were infected with rAAV-TFPI-2. Further, we observed a large reduction of tumor growth in SNB19 cells treated with rAAV-TFPI-2 virus injected intracerebrally when compared to controls. Our study demonstrates that rAAV-TFPI-2-mediated gene therapy offers a novel tool for the treatment of brain tumors. 相似文献
106.
107.
Zhijie Dai Sookja K Chung Dengshun Miao Kam S Lau Alfred WH Chan Annie WC Kung 《Journal of bone and mineral research》2011,26(3):582-590
myo‐Inositol (MI) plays an essential role in several important processes of cell physiology, is involved in the neural system, and provides an effective treatment for some psychiatric disorders. Its role in osteogenesis and bone formation nonetheless is unclear. Sodium/MI cotransporter 1 (SMIT1, the major cotransporter of MI) knockout (SMIT1?/?) mice with markedly reduced tissue MI levels were used to characterize the essential roles of MI and SMIT1 in osteogenesis. SMIT1?/? embryos had a dramatic delay in prenatal mineralization and died soon after birth owing to respiratory failure, but this could be rescued by maternal MI supplementation. The rescued SMIT1?/? mice had shorter limbs, decreased bone density, and abnormal bone architecture in adulthood. Deletion of SMIT1 resulted in retarded postnatal osteoblastic differentiation and bone formation in vivo and in vitro. Continuous MI supplementation partially restored the abnormal bone phenotypes in adult SMIT1?/? mice and strengthened bone structure in SMIT1+/+ mice. Although MI content was much lower in SMIT1?/? mesenchymal cells (MSCs), the I(1,4,5)P3 signaling pathway was excluded as the means by which SMIT1 and MI affected osteogenesis. PCR expression array revealed Fgf4, leptin, Sele, Selp, and Nos2 as novel target genes of SMIT1 and MI. SMIT1 was constitutively expressed in multipotential C3H10T1/2 and preosteoblastic MC3T3‐E1 cells and could be upregulated during bone morphogenetic protein 2 (BMP‐2)–induced osteogenesis. Collectively, this study demonstrated that deficiency in SMIT1 and MI has a detrimental impact on prenatal skeletal development and postnatal bone remodeling and confirmed their essential roles in osteogenesis, bone formation, and bone mineral density (BMD) determination. © 2011 American Society for Bone and Mineral Research. 相似文献
108.
Olivero G Durazzo M Bertello A Volante M Pellicano R Bini R 《Minerva gastroenterologica e dietologica》2006,52(4):437-440
The rare association between Von Recklin-ghausen's disease (VRD) and tumours other than in central nervous system is well recognized. However, the concomitance of VRD, a carcinoid of the ampulla of Vater, and a pheochromocytoma has been described very rarely in literature. Furthermore, the possible role of the genes usually involved in multiple endocrine neoplasia (MEN) syndromes, in this association, is unclear. We report the case of a patient affected by VRD and extra-adrenal pheochromocytoma, operated on in the past for a carcinoid of the ampulla of Vater. To determine if genes involved in MEN syndromes might play a role in this particular triad, we investigated the presence of somatic or germline mutations in the RET proto-oncogene and menin gene by non isotopic polymerase chain reaction single stranded conformation polymorphism (PCR-SSCP) and heteroduplex gel electro-phoresis. The results demonstrated that no somatic or germline mutations in the MEN-1 and MEN-2 genes were involved in the pathogenesis of these tumours. 相似文献
109.
110.
Folkes AJ Ahmadi K Alderton WK Alix S Baker SJ Box G Chuckowree IS Clarke PA Depledge P Eccles SA Friedman LS Hayes A Hancox TC Kugendradas A Lensun L Moore P Olivero AG Pang J Patel S Pergl-Wilson GH Raynaud FI Robson A Saghir N Salphati L Sohal S Ultsch MH Valenti M Wallweber HJ Wan NC Wiesmann C Workman P Zhyvoloup A Zvelebil MJ Shuttleworth SJ 《Journal of medicinal chemistry》2008,51(18):5522-5532
Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/ Akt signaling pathway in a wide variety of tumors. A series of thieno[3,2-d]pyrimidine derivatives were prepared and evaluated as inhibitors of PI3 kinase p110alpha. The synthesis, biological activity, and further profiling of these compounds are described. This work resulted in the discovery of 17, GDC-0941, which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clinical trials for the treatment of cancer. 相似文献